Written Question·Department of Health and Social Care·UIN 44145

Methylphenidate and Pancreatic Enzyme Replacement Therapy

Tabled: 3 April 2025

Answered: 9 April 2025

Question

Jess Brown-Fuller

To ask the Secretary of State for Health and Social Care, what progress he has made on increasing the availability of (a) methylphenidate and (b) pancreatic enzyme replacement therapy.

Answer

Karin Smyth

As a result of intensive work, some issues with attention deficit hyperactivity disorder medicines have resolved. All strengths of lisdexamfetamine, atomoxetine capsules, atomoxetine oral solution, and guanfacine prolonged-release tablets are now availabl...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 44145) →